Trials / Unknown
UnknownNCT04249063
Fundal Block in Pre-menopausal Women to Reduce Pain During Outpatient-based Endometrial Ablation (FUNDAL-PAIN)
FUndal Block During NovaSure enDometrial AbLation to Reduce Intraoperative PAIN: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 288 (estimated)
- Sponsor
- Saskatchewan Health Authority - Regina Area · Academic / Other
- Sex
- Female
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the efficacy of a fundal block in reducing women's perception of pain during NovaSure endometrial ablation (EA) in an outpatient-based setting.
Detailed description
The researchers aim to determine whether participants receiving the paracervical and fundal block (experimental group) achieve clinically and statistically significant reductions in self-reported pain during NovaSure EA, as compared to those receiving paracervical block (control group). All women will obtain concurrent procedural sedation. Women's perception of pain will be recorded on a scale from 0 to 10 using the visual analogue scale (VAS). The researchers hypothesize that the participants receiving combined paracervical and fundal block will experience less pain during the active procedure, as compared to those receiving paracervical block alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xylocaine 1 % and Normal Saline | 3cc aliquots of local anaesthetic will be injected into the right and left cornual regions and centrally in the fundus. This will be achieved by using a flexible hysteroscopic needle. |
| DRUG | Normal Saline | 3cc aliquots of normal saline will be injected into the right and left cornual regions and centrally in the fundus. This will be achieved by using a flexible hysteroscopic needle. |
Timeline
- Start date
- 2021-01-18
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2020-01-30
- Last updated
- 2023-05-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04249063. Inclusion in this directory is not an endorsement.